GGrantIndex
Sort

326,823 grants matching clinical trial

The Delaware Comprehensive Sickle Cell Research Center

$2,092,666
David C Brousseau · Nemours Children'S Hospital, Delaware · P20 · FY2022 · GM

A selective angiogenesis blocker to treat retinopathy of prematurity

$2,092,566
Wei Li · Baylor College Of Medicine · R24 · FY2021 · EY

Host and Microbial Metabolism in Graft versus Host Disease

$2,092,435
Muneesh Tewari · University Of Michigan At Ann Arbor · P01 · FY2024 · HL

Conus Peptides and Their Receptor Targets

$2,092,340
Baldomero M Olivera · University Of Utah · P01 · FY2008 · GM

Integrated heart-liver-vascular systems for drug testing in human health and dise

$2,092,321
Gordana Vunjak-Novakovic · Columbia Univ New York Morningside · UH3 · FY2014 · EB

CENTER FOR HUMAN CELL THERAPY

$2,092,141
Immune Disease Institute, Inc. · U24 · FY2005 · HL

1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial

$2,092,028
Robert J Kaner · Weill Medical Coll Of Cornell Univ · UH3 · FY2023 · HL

UT M.D. Anderson Cancer Center

$2,091,787
Michael Jordan Fisch · University Of Tx Md Anderson Can Ctr · U10 · FY2009 · CA

A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome

$2,091,549
Zhiyong Yang · Fzata, Inc. · UG3 · FY2024 · NS

Autism Adaptive Community-based Treatment to Improve Outcomes using Navigators (ACTION) Network

$2,091,546
Amy M Wetherby · Florida State University · R01 · FY2018 · HD

Translational Research in Breast Cancer

$2,091,509
Xiang Zhang · Baylor College Of Medicine · P50 · FY2022 · CA

Mayo Clinic Multiple Myeloma SPORE

$2,091,215
Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2021 · CA

Washington University SPORE in Pancreatic Cancer

$2,091,214
David G Denardo · Washington University · P50 · FY2024 · CA

Development of an Anti-P-selectin Antibody for the Treatment of Sickle Cell Disea

$2,091,208
Scott A Rollins · Selexys Pharmaceuticals Corporation · R44 · FY2010 · HL

1/3 Effectiveness Trial of the Early Social Interaction (ESI) Model using Mobile Technology for Toddlers with Autism Identified from Early Screening in Primary Care

$2,091,087
Amy M Wetherby · Florida State University · R01 · FY2023 · MH

Developmental Therapeutics Program

$2,090,969
Richard D Schulick · University Of Colorado Denver · P30 · FY2024 · CA

Developmental Therapeutics Program

$2,090,964
Richard D Schulick · University Of Colorado Denver · P30 · FY2023 · CA

Improving Oral Health with Serious Games

$2,090,845
Howard Andrew Rose · Firsthand Technology, Inc. · R44 · FY2008 · DE

Neuroblastoma Biology and Therapy

$2,090,796
Childrens Hospital Of Philadelphia · P01 · FY2004 · CA

Costimulatory Mechanisms of Autoimmunity (Composite)

$2,090,661
David A. Hafler · Yale University · P01 · FY2016 · AI

HIV Vaccine Design and Development Team

$2,090,481
Progenics Pharmaceuticals, Inc. · R01 · FY2001 · AI

Molecular Mechanism of Action of Phorbol Ester

$2,090,269
Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

MD Anderson Gynecologic SPORE for Uterine Cancers

$2,090,228
Karen Hsieh Lu · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA

University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection

$2,090,181
Anna Wald · University Of Washington · U19 · FY2020 · AI

Characterizing and Targeting Pyk2 Kinase in Alzheimer’s Disease

$2,090,105
Stephen M Strittmatter · Yale University · RF1 · FY2016 · AG